UP - logo
E-viri
Recenzirano Odprti dostop
  • 30 years of CIK cell therap...
    Sharma, Amit; Schmidt-Wolf, Ingo G H

    Journal of experimental & clinical cancer research, 12/2021, Letnik: 40, Številka: 1
    Journal Article

    Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.